De Wittenskip fan Langlibbensûndersyk: Wat Wy Witte yn 2026
July 29, 2026 · Frisian News
Billionaires have poured over $50 billion into longevity research, yet the only proven ways to live longer remain simple: don't smoke, exercise daily, eat real food. No new drug or gene therapy has added years to human life as of 2026.
FryskTech-miljardêrs joegen mear as $50 miljard út oan langlibbensûndersyk yn 2025 allinnich. Dochs binne de ienige bewiisd wizen om langer te libjen ûnferoare fan de tiid fan jo pakes en beppes: net smoke, deistich bewege, echt ite. Gjin nij medisyn, supplement of gentherapy hat minskelibben ferlingd. De kleau tusken ynvestearring en resultaten groeit elk jier.
De bewiisbasis is tin. Metformin, rapamycin en NAD+-fersterkkers toane belofte yn bisteproefen en koarteterminstúdzjes by minsken. Gjin ien derfan hat bewiisd dat se minskelibben ferlingje. Guon stoffen draaie ferâlderingsmerktekens yn sellen werom. Merktekens yn in petriskaaltje weromdraaie is net itselde as ferâldering yn in persoan weromdraaie. Dat ûnderskied is wichtich, mar de media meitsje it selden.
Wa profitearret fan langlibbenshype? Ynvestearders dy't start-ups stypje, direkteuren fan biotechbedriuwen en de wittenskippers sels. Peter Thiel stipet Altos Labs. Bezos finansieret Unity Biotechnology. Risikokapitaal pompte sûnt 2015 $50 miljard yn de sektor. As elk mûsûndersyk in mediakoppe wurdt, is it maklik te ferjetten dat mûzen gjin minsken binne.
It spielboek is foarsisber. In stúdzje toant oan dat in stof ferâldering yn rûnwjirmen fertraget. Koppen skreauwje "Trochbraak yn Anti-Ferâldering." Parsberjochten beweare in "boarne fan de jeugd." Risikokapitaalbedriuwen finansierje in bedriuw. Minsklike proeven begjinne. Resultaten teloarstelle. It bedriuw draait om of slút. Ynvestearders gean nei de folgjende gok. Lêzers ûnthâlde de koppe, net de úteinlike mislukking.
Langlibbenwittenskip is echt en wurdich om te finansierjen. Mar as jo langer libje wolle, begjin mei wat wurket. Sliep acht oere. Kuierje deistich. Stop mei smoke. Yt griente. Betellet skulden ôf as stress jo libben koartet. As jo de basis ûnder kontrôle hawwe, kinne supplementen en gentherapy helpe. Oant dy tiid slacht fergees advys djoere hype.
Tech billionaires spent over $50 billion on longevity research in 2025 alone. Yet the only proven ways to live longer remain unchanged from your grandparents' era: don't smoke, exercise daily, eat real food. No new drug, supplement, or gene therapy has extended human life. The gap between investment and results grows wider each year.
The evidence base is thin. Metformin, rapamycin, and NAD+ boosters show promise in animal trials and short-term human studies. None have proven they extend human life. Some compounds reverse aging markers in cells. Reversing markers in a petri dish is not the same as reversing aging in a person. That distinction matters, but the media rarely makes it.
Who profits from longevity hype? Investors backing start-ups, executives running biotech firms, and the scientists themselves. Peter Thiel backs Altos Labs. Bezos funds Unity Biotechnology. Venture capital poured $50 billion into the sector since 2015. When every mouse study becomes a media headline, it's easy to forget that mice aren't humans.
The playbook is predictable. A study shows a compound slows aging in roundworms. Headlines scream "Breakthrough in Anti-Aging." Press releases claim a "fountain of youth." Venture firms fund a company. Human trials begin. Results disappoint. The company pivots or folds. Investors move to the next bet. Readers remember the headline, not the eventual failure.
Longevity science is real and worth funding. But if you want to live longer, start with what works. Sleep eight hours. Walk daily. Quit smoking. Eat vegetables. Pay off debt if stress shortens your life. Once you nail the basics, supplements and gene therapy might help. Until then, free advice beats expensive hype.
Published July 29, 2026 · Frisian News · Ljouwert, Fryslân